Bio Sequence

Biological Glossary | What is Neoantigen?

17 November 2023
2 min read

In biology, a neoantigen refers to a novel antigen that arises from a mutation in the DNA of a normal cell. This mutation causes an alteration in the amino acid sequence of a protein, leading to the generation of a different protein structure that the immune system can recognize as foreign or "non-self."

The significance of neoantigens becomes particularly pronounced in cancer biology. Cancer cells undergo numerous DNA mutations that lead to the creation of new, abnormal proteins. These mutation-induced proteins are recognized by the body’s immune system as neoantigens because they are not found in healthy cells.

Neoantigens play a critical role in cancer immunotherapy since they are:

Tumor-specific: These antigens are unique to cancer cells and not present in normal cells, making them ideal targets for personalized immunotherapy treatments.

Immunogenic: They can stimulate a robust immune response as T cells can identify neoantigens as foreign entities, similar to how they recognize pathogens.

Involved in treatment response: The presence and burden of neoantigens within a tumor can influence the outcome and effectiveness of immunotherapy treatments such as checkpoint blockade inhibitors (e.g., anti-CTLA4, anti-PD1) and personalized cancer vaccines.

Research and therapeutic targets: The discovery and profiling of neoantigens with techniques like next-generation sequencing and RNA-seq technologies help to understand tumor immunogenicity, devise new treatment strategies, and potentially lead to the development of more effective and less toxic cancer therapies.

Overall, neoantigens are increasingly acknowledged for their potential to drive personalized cancer immunotherapy, creating optimism for more selective and efficacious treatment options that leverage the body's natural defense mechanisms.

Free registration is available for the Bio biological sequence database: https://bio.patsnap.com. Act now to expedite your sequence search tasks.

图片包含 图示

描述已自动生成

BioRay begins Phase I trial for BRY812, a novel LIV-1 antibody drug conjugate, with its first patient
Latest Hotspot
3 min read
BioRay begins Phase I trial for BRY812, a novel LIV-1 antibody drug conjugate, with its first patient
17 November 2023
BioRay introduces the initiation of its Phase I clinical trial with the first patient for BRY812, a new LIV-1 focused antibody drug conjugate.
Read →
What are CDK4 inhibitors and how do you quickly get the latest development progress?
What are CDK4 inhibitors and how do you quickly get the latest development progress?
17 November 2023
CDK4 inhibitors can inhibit the formation of complexes between CDK4 and cyclin D, block ATP binding, thereby severing upstream growth signals, and prevent the transition from G1 to S phase.
Read →
Biological Glossary | What is Mutation?
Bio Sequence
2 min read
Biological Glossary | What is Mutation?
17 November 2023
In biology, a mutation is a permanent alteration to the nucleotide sequence of the genome of an organism, virus, or extrachromosomal DNA.
Read →
Ventyx Biosciences announces Phase 2 results for VTX958 in psoriasis and provides a company update
Latest Hotspot
3 min read
Ventyx Biosciences announces Phase 2 results for VTX958 in psoriasis and provides a company update
17 November 2023
Ventyx Biosciences reports outcomes of the second phase study of VTX958 in moderate-to-severe plaque psoriasis patients and delivers a company update.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.